Overview
1. Therapy of neuromuscular disease - immunologic and neuromuscular facilitating agents for myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS).
2. Clinical trials in nerve, muscle and neuromuscular diseases
Current Appointments & Affiliations
Professor Emeritus of Neurology
·
2025 - Present
Neurology, Neuromuscular Disease,
Neurology
Recent Publications
The Duke MG Patient Registry III. Comparative Effectiveness of Azathioprine and Mycophenolate Mofetil in Generalized Myasthenia Gravis, a Retrospective Single Center Review.
Conference Muscle Nerve · May 2026 INTRODUCTION/AIMS: Azathioprine (AZA) and mycophenolate mofetil (MMF) are the most commonly used non-steroidal immunosuppressants in patients with generalized myasthenia gravis (gMG) in North America but their relative effectiveness among disease subgroups ... Full text Link to item CiteImmunotherapies in autoimmune neuromuscular junction disorders: Acute and chronic management.
Journal Article Handb Clin Neurol · 2026 Myasthenia gravis (MG) is the most common disease of the neuromuscular junction. Conventional immunotherapy based on corticosteroids and immunosuppressants has been in use for several decades and has greatly contributed to the improvement of the disease pr ... Full text Link to item CiteSensitivity of Repetitive Nerve Stimulation Performed in Early and Later Stages of Myasthenia Gravis.
Journal Article Muscle Nerve · October 2025 INTRODUCTION/AIMS: Repetitive nerve stimulation (RNS) is a valuable tool in the diagnostic evaluation of myasthenia gravis (MG). However, there are conflicting reports of its sensitivity when performed ≤ 30 days from symptom onset. We aim to compare the se ... Full text Link to item CiteRecent Grants
Defining the clinical phenotype and immunopathology of seronegative MG
ResearchKey Faculty · Awarded by Myasthenia Gravis Foundation · 2021 - 2023Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-Modifying Treatments for Myasthenia Gravis (MG)
Clinical TrialPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2017 - 2022Real World Outcomes of Surgical and Medical Management in Myasthenia Gravis
ResearchMentor · Awarded by American Academy of Neurology · 2019 - 2022View All Grants
Education
Harvard University ·
1964
M.D.